Skip to main content

Advertisement

SpringerLink
Log in

Impaired autologous mixed lymphocyte reactivity in Hodgkin's disease

Gestörte Lymphozytenreaktivität in der autologen gemischten Lymphozytenkultur bei Morbus Hodgkin

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

In patients with Hodkin's disease, the impaired immune reactivity, especially of the thymus dependent system, is well established. This decreased immune response of the lymphocytes from the peripheral blood contrasts to an increased lymphocytopoiesis in the lymphatic organs with a hyperplasia of these tissues. We studied the reactivity of peripheral T lymphocytes from 20 patients with Hodgkin's disease and 26 healthy control persons against autologous and allogeneic non T cells respectively in the mixed lymphocyte culture (MLC). Our experiments show an extremely depressed autologous mixed lymphocyte reactivity (MLR) of T lymphocytes from patients with Hodgkin's disease compared to those from normal donors. In the allogeneic MLC, the proliferation of the patients' T cells was stronger than in the autologous MLC, but significantly lower than the proliferation of normal T lymphocytes when stimulated by normal non T cells. Patients' non T cells stimulated T lymphocytes from healthy donors as well as non T lymphocytes from normals did. Finally, the autologous MLR of normal lymphocytes was significantly suppressed by 18 of 23 sera from Hodgkin's patients when these sera were substituted for normal AB serum in the cultures. These results demonstrate an impaired function of T lymphocytes from patients with Hodgkin's disease in the autologous MLC and the presence of one or more factors in their serum which inhibit the proliferation of normal lymphocytes in the autologous MLC. The role of suppressor cells and their factors will be discussed.

Zusammenfassung

Die gestörte Funktion des Immunsystems, besonders die der zellulären Immunabwehr ist bei Patienten mit Morbus Hodgkin seit langem bekannt. Dabei steht der verminderten Reaktivität der peripheren Blutlymphozyten eine gesteigerte Lymphozytopoese in lymphatischen Organen mit Hyperplasie dieser Gewebe gegenüber. Wir untersuchten die Reaktivität peripherer T-Lymphozyten von 20 Patienten mit Morbus Hodgkin und 26 gesunden Kontrollpersonen gegen autologe und allogene Nicht-T-Lymphozyten in der gemischten Lymphozytenkultur (MLC). Unsere Versuche hatten folgende Ergebnisse: (1) T-Lymphozyten von Morbus Hodgkin-Patienten werden nicht oder nur sehr schwach in der autologen MLC stimuliert. (2) In der allogenen MLC reagieren T-Zellen von Patienten deutlich stärker als in der autologen MLC, jedoch significant geringer als normale T-Lymphozyten gegen normale Nicht-T-Lymphozyten. Nicht-T-Zellen von Patienten stimulieren dagegen allogene T-Lymphozyten von Gesunden kaum weniger als normale Nicht-T-Zellen. (3) Wird eine autologe MLC mit Lymphozyten gesunder Spender, jedoch mit Serum von Patienten mit Morbus Hodgkin durchgeführt, zeigt sich eine signifikante, dosisabhängige Verminderung der Reaktivität gegenüber Kontrollen mit Serum von Normalpersonen. Diese Ergebnisse zeigen zusammengefaßt bei Patienten mit Morbus Hodgkin eine gestörte Funktion der T-Lymphozyten in der autologen MLC und die Existenz eines oder mehrerer Serumfaktoren, die die Proliferation von T-Lymphozyten gesunder Personen in der autologen MLC hemmen. Die Rolle von Suppressorzellen und derer Faktoren als Ursache für diese Befunde wird diskutiert.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Amlot PL, Slaney JM, Williams BD (1976) Circulating immune complexes and symptoms in Hodgkin's disease. Lancet 1:449

    Google Scholar 

  2. Bach FH, Voynow NK (1966) One-way stimulation in mixed lymphocyte culture. Science 153:545-

    Google Scholar 

  3. Begemann M, Claas G (1979) Suppression of autologous mixed lymphocyte reactivity by serum from patients with Hodgkin's disease. Immunobiol 156:264 (Abstract)

    Google Scholar 

  4. Begemann M, Claas G, Falke H (1980) Hemmung der autologen gemischten Lymphocytenkultur bei Morbus Hodgkin. Verh Dtsch Ges Inn Med 86:1055

    Google Scholar 

  5. Bieber MM, Fuks Z, Kaplan HS (1977) E-rosette inhibiting substance in Hodgkin's disease spleen extracts. Clin Exp Immunol 29:369

    Google Scholar 

  6. Böyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21: [Suppl 97]:77

    Google Scholar 

  7. Carbone PP, Kaplan HS, Musshoff KJ, Smithers DW, Tubiana M (1971) Report of committee on Hodgkin's disease staging classification. Cancer Res 31:1860

    Google Scholar 

  8. Desforges JF, Rutherford CJ, Piro A (1979) Hodgkin's disease. N Engl. J Med 301:1212

    Google Scholar 

  9. de Hazo RD (1980) Indomethacin-responsive mononuclear cell dysfunction in Hodgkin's disease. Clin Immunol Immunopathol 17:66

    Google Scholar 

  10. de Vita VT (1973) Lymphocyte reactivity in Hodgkin's disease: a lymphocyte civil war. N Engl J Med 289:801

    Google Scholar 

  11. Engleman EG, Benike C, Hoppe RT, Kaplan HS (1979) Suppressor cells of the mixed lymphocyte reaction in patients with Hodgkin's disease. Transplant Proc XI:1827

    Google Scholar 

  12. Engleman EG, Benike CJ, Hoppe RT, Kaplan HS (1980) Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect. J Clin Invest 66:149

    Google Scholar 

  13. Fuks Z, Strober S, Kaplan HS (1976) Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test. N Engl J Med 295:1273

    Google Scholar 

  14. Glöckel U, Stasing C, Koch B, Leitner O, Kalden JR (1980) Autologous MLC reactivity (AMLC) in patients with rheumatoid arthritis (RA). Immunobiol 157:221 (Abstract)

    Google Scholar 

  15. Goodwin JS, Bankhurst AD, Messner RP (1977) Suppression of human T cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med 146:1719

    Google Scholar 

  16. Goodwin JS, Messner RP, Bankhurst AD, Peake GT, Saiki JH, Williams RC (1977) Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med 297:963

    Google Scholar 

  17. Goodwin JS, Webb DR (1980) Regulation of the immune response by prostaglandins. Clin Immunol Immunopathol 15:106

    Google Scholar 

  18. Grifoni V, del Giaco GS, Manconi PE, Tognella S (1972) Surface immunoglobulins on lymphocytes in Hodgkin's disease. Lancet 1:848

    Google Scholar 

  19. Haakenstadt AO, Mannik M (1977) The biology of immune complexes. In: N Talal (ed) Automimmunity. Academic Press, New York, p 277

    Google Scholar 

  20. Hillinger SM, Herzig GP (1978) Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes. J Clin Invest 61:1620

    Google Scholar 

  21. James SP, Elson CO, Waggoner JG, Jones EA, Strober W (1980) Deficiency of the autologous mixed lymphocyte reaction in patients with primary biliary cirrhosis. J Clin Invest 66:1305

    Google Scholar 

  22. Kabelitz D, Fink U, Flad HD, Rastetter J (1977) Lack of autologous MLC reaction in chronic lymphatic leukemia. Z Immun-Forsch 153:313 (Abstract)

    Google Scholar 

  23. Kaplan HS (1976) Hodgkin's disease and other human malignant lymphomas: advances and prospects — G.H.A. Clowes memorial lecture. Cancer Res 36:3863

    Google Scholar 

  24. Kaplan HS (1980) Hodgkin's Disease: Unfolding concepts concerning its nature, management and prognosis. Cancer 45:2439

    Google Scholar 

  25. Kaplan HS, Smithers DW (1959) Autoimmunity in man and homologous disease in mice in relation to malignant lymphomas. Lancet 2:1

    Google Scholar 

  26. Kruskal WH, Wallis WA (1957) Use of ranks in one-criterion variance analysis. J Am Statist Assoc 47:583

    Google Scholar 

  27. Kuntz MM, Innes JB, Weksler ME (1976) Impaired immune surveillance in chronic lymphocytic leukemia (CLL) and systemic lupus erythematosus (SLE). Clin Res 24:448 A (Abstract)

    Google Scholar 

  28. Kuntz MM, Innes JB, Weksler ME (1976) Lymphocyte transformation induced by autologous cells. IV. Human T lymphocyte proliferation induced by by autologous or allogeneic non T lymphocytes. J Exp Med 143:1042

    Google Scholar 

  29. Kuntz MM, Innes JB, Weksler ME (1979) The cellular basis of the impaired autologous mixed lymphocyte reaction in patients with systemic lupus erythematosus. J Clin Invest 63:151

    Google Scholar 

  30. Long JC (1979) The immunopathology of Hodgkin's disease. Clin Haematol 8:531

    Google Scholar 

  31. Lukes RJ, Craver LF, Hall TC, Rappaport H, Rubin P (1966) Part 1. Report of the nomenclature committee. Cancer Res 26:1311

    Google Scholar 

  32. Miller RA, Kaplan HS (1978) Generation of cytotoxic lymphocytes in the autologous mixed lymphocyte culture. J Immunol 121:2165

    Google Scholar 

  33. Miyasaka N, Sauvezie B, Pierce DA, Daniels TE, Talal N (1980) Decreased autologous mixed lymphocyte reaction in Sjögren's syndrome. J Clin Invest 66:928

    Google Scholar 

  34. Moody CE, Casazza BA, Christenson WN, Weksler ME (1979) Lymphocyte transformation by autologous cells. VIII. Impaired autologous mixed lymphocyte reactivity in patients with acute infectious mononucleosis. J Exp Med 150:1448

    Google Scholar 

  35. Moretta L, Mingari MC, Moretta A (1979) Human T cell subpopulations in normal and pathologic conditions. Immunol Rev 45:163

    Google Scholar 

  36. Moretta L, Webb SR, Grossi CE, Lydyard PM, Cooper MD (1977) Functional analysis of two human T cell subpopulations: Help and suppression of B cell responses by T cells bearing receptors for IgM (TM) or IgG (TG). J Exp Med 146:184

    Google Scholar 

  37. Offner H, Clausen J (1974) Inhibition of lymphocyte response to stimulants induced by unsatured fatty acids and prostaglandins. Lancet 2:400

    Google Scholar 

  38. Opelz G, Kiuchi M, Takasugi M, Terasaki PI (1975) Autologous stimulation of human lymphocyte subpopulations. J Exp Med 142:1327

    Google Scholar 

  39. Order SE, Hellmann S (1972) Pathogenesis of Hodgkin's disease. Lancet 1:571

    Google Scholar 

  40. Reed DM (1902) On the pathological changes in Hodgkin's disease, with especial reference to its relation to tuberculosis. John Hopkins Hosp Rep 10:133

    Google Scholar 

  41. Romagnani S, Maggi E, Biagiotti R, Giudizi MG, Amadori A, Ricci M (1978) Altered proportion of Tμ and Tγ-cell subpopulations in patients with Hodgkin's disease. Scand J Immunol 7:511

    Google Scholar 

  42. Sachs L (1968) Statistische Auswertungsmethoden. Springer, Berlin Heidelberg New York

    Google Scholar 

  43. Sakane T, Green JI (1979) Specificity and suppressor function of human T cells responsive to autologous non T cells. J Immunol 123:584

    Google Scholar 

  44. Sakane T, Steinberg AD, Green I (1978) Failure of autologous mixed lymphocyte reaction between T and non T cells in patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 75:3464

    Google Scholar 

  45. Schechter GP, Soehnlen F (1978) Monocyte-mediated inhibition of lymphocyte blastogenesis in Hodgkin's disease. Blood 52:261

    Google Scholar 

  46. Scheurlen PG, Schneider W, Pappas A (1971) Inhibition of transformation of normal lymphocytes by plasma factor from patients with Hodgkin's disease and cancer. Lancet 2:1265

    Google Scholar 

  47. Scheurlen PG, Schneider W, Pappas A (1972) Identifizierung eines Lymphocytenhemmfaktors im Serum von Patienten mit malignen Tumoren. Verh Dtsch Ges Inn Med 78:129

    Google Scholar 

  48. Seiler FR, Sedlacek HH, Kanzy EJ, Lang W (1972) Über die Brauchbarkeit immunologischer Nachweismethoden zur Differenzierung funktionell verschiedener Lymphozyten: Spontanrosetten, Komplementreceptor-Rosetten, und Immunglobulinrezeptoren. Behring Inst Mitt 52:26

    Google Scholar 

  49. Sibbitt WL, Bankhurst AD, Williams RC (1978) Studies of cell subpopulations mediating mitogen hyporesponsiveness in patients with Hodgkin's disease. J Clin Invest 61:55

    Google Scholar 

  50. Sinkovics JG, Shullenberger CC (1975) Hodgkin's disease (Letter). Lancet 2:506

    Google Scholar 

  51. Smith JB, Knowlton RP (1979) Activation of suppressor T lymphocytes in human autologous mixed lymphocyte culture. J Immunol 123:419

    Google Scholar 

  52. Smith JB, Knowlton RP, Koons LS (1977) Immunologic studies in chronic lymphocytic leukemia: defective stimulation of T cell proliferation in autologous mixed lymphocyte culture. J Natl Cancer Inst 58:579

    Google Scholar 

  53. Stockman GD, Mumford DM (1974) The effect of prostaglandins on the in vitro blastogenic response of human peripheral blood lymphocytes. Exp Haematol 2:65

    Google Scholar 

  54. Sugden PJ, Lilleyman JS (1980) Impairment of lymphocyte transformation by plasma from patients with advanced Hodgkin's disease. Cancer 45:899

    Google Scholar 

  55. Tomonari K (1980) Cytotoxic T cells generated in the autologous mixed lymphocyte reaction. I. Primary autologous mixed lymphocyte reaction. J Immunol 124:1111

    Google Scholar 

  56. Trepel F, Schick P (1977) Morbus Hodgkin — eine atypische Immunreaktion. Med Klin 72:1003

    Google Scholar 

  57. Twomey JJ, Laughter AH, Farrow S, Douglass CC (1975) Hodgkin's disease. An immunodepleting and immunosuppressive disorders. J Clin Invest 56:467

    Google Scholar 

  58. Van de Stouwe RA, Kunkel HG, Halper JP, Weksler ME (1977) Autologous mixed lymphocyte culture reactions and generation of cytotoxic T cells. J Exp Med 146:1809

    Google Scholar 

  59. Webb DR, Jamieson AT (1976) Control of mitogen-induced transformation: Characterisation of a splenic suppressor cell and its mode of action. Cell Immunol 24:45

    Google Scholar 

  60. Webb DR, Nowowiejski I (1978) Mitogen-induced changes in lymphocyte prostaglandin levels: A signal for the induction of suppressor cell activity. Cell Immunol 41:72

    Google Scholar 

  61. Webb DR, Osheroff PL (1976) Antigen stimulation of prostaglandin synthesis and control of immune response. Proc Natl Acad Sci USA 73:1300

    Google Scholar 

  62. Weir DM (ed) (1978) Handbook of experimental immunology, 3d edn. Blackwell, Oxford London Edinburgh Melbourne

    Google Scholar 

  63. Weksler ME, Kozak R (1977) Lymphocyte transformation induced by autologous cells. V. Generation of immunologic memory and specificity during the autologous mixed lymphocyte reaction. J Exp Med 146:1833

    Google Scholar 

  64. Yam LT, Li CY, Crosby WH (1971) Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 55:183-

    Google Scholar 

  65. Zorini CO, Neri A, Comis M, Manella E, Paciucci PA (1974) Influence of Hodgkin's serum on PHA stimulation of normal lymphocytes. Lancet 1:745

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Hämatologie und Onkologie im Zentrum für Innere Medizin der Philipps-Universität Marburg, Germany

    M. Begemann, G. Claas & H. Falke

Authors
  1. M. Begemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Claas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Falke
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported by the Deutsche Forschungsgemeinschaft

Rights and permissions

Reprints and permissions

About this article

Cite this article

Begemann, M., Claas, G. & Falke, H. Impaired autologous mixed lymphocyte reactivity in Hodgkin's disease. Klin Wochenschr 60, 19–26 (1982). https://doi.org/10.1007/BF01721583

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01721583

Key words

Schlüsselwörter

Search

Navigation